Bina Rajesh Ghatalia's Insider Trades & SAST Disclosures
Bina Rajesh Ghatalia's most recent trade in Aarey Drugs & Pharmaceuticals Ltd. was a Acquisition of 500,000 Equity Shares done at an average price of Rs. 32 . Disclosure was reported to the exchange on June 23, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Bina Rajesh Ghatalia in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aarey Drugs & Pharma | Bina Rajesh Ghatalia | Promoter | Acquisition | 23 Jun 2022 | 500,000 | 4,000,834 (15.76%) | 1.97% | 32 | 16,000,000 | 23 Jun 2022 23 Jun 2022 |
Insider Trading | Equity Shares | Off Market |
| Aarey Drugs & Pharma | Bina Rajesh Ghatalia | Promoter | Acquisition | 14 Dec 2021 | 150,000 | 3,500,834 (13.79%) | 0.64% | 41.2 | 6,174,000 | 25 Nov 2021 25 Nov 2021 |
Insider Trading | Equity Shares | Allotment |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.